R. Nolan Townsend is Chief Executive Officer and Director of Lexeo Therapeutics, Inc. (LXEO). The company reported total compensation of $3,650,940 for fiscal year 2025.
| Salary | $632,700 |
|---|---|
| Bonus | $0 |
| Stock awards | $1,493,488 |
| Option awards | $1,165,982 |
| Non-equity incentive plan | $347,985 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $10,785 |
| Total | $3,650,940 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Lexeo Therapeutics, Inc. filed April 30, 2026, accession 0001193125-26-193930.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer and Director | $632,700 | $0 | $1,493,488 | $1,165,982 | $347,985 | $0 | $10,785 | $3,650,940 |
| FY2024 | Chief Executive Officer and Director | $600,000 | $0 | $633,500 | $2,833,754 | $297,000 | $0 | $10,994 | $4,375,248 |
Totals as disclosed in each year's own compensation disclosure for Lexeo Therapeutics, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| R. Nolan Townsend this page | Chief Executive Officer and Director | $3,650,940 |
| Jenny Robertson | Former Chief Legal Officer | $2,145,883 |
| Louis Tamayo | Chief Financial Officer | $1,665,915 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Lexeo Therapeutics, Inc. compensation brief.
R. Nolan Townsend's compensation sits inside Lexeo Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.